Page 90 - Sohini Das

Govt begins micro-planning for administering Covid-19 vaccine to the masses

Centre has asked states to update databases, train manpower, indicate resource requirements

We can make over 1.5 bn doses in 2021: Biological E MD & CEO Mahima Datla

Though our target is a billion doses, we may have an upside as we are evaluating various doses in the phase-1 and -2 studies, said Datla

Immunity hurdle for a shot at Covid vaccine; govt working on priority list

Rapid antibody tests at dedicated Covid-19 vaccination centres to act as screening tool

Piramal Pharma readies war chest for potential acquisition targets

A decade after Piramal sold its domestic formulations business to Abbott Laboratories for $3.72 billion, the group is now looking at re-entering the space in India

Cardiac, vitamin drugs see pharma sales rebound with 4.5% growth in Sept

Industry says fresh prescriptions are picking up

Covid-19 vaccine: Bharat Biotech to use Kansas firm's adjuvant for Covaxin

Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

With phase 4 clinical trials now on, the sales may see a further uptick if data supports its use on Covid-19 patients, said experts.

Indigenous players on a slow and steady coronavirus vaccine race

Smaller players are bullish on playing crucial role in nation's vaccine infrastructure

Patented molecules clock a high growth rate in Indian cardiovascular market

In January 2020, the Delhi High Court granted an injunction restraining domestic companies such as Cipla, Torrent, Emcure, and Alkem from launching their brands

Covid-19: 8% super-spreaders account for 60% new infections, says study

The findings are part of a survey conducted by the Center For Disease Dynamics, Economics & Policy (CDDEP) along with governments of Tamil Nadu and Andhra Pradesh

Revised, more industry-friendly PLI scheme for bulk drugs on the cards

Industry says move will mean lower spends and reduced dependence on China

Covid-19: Dr Reddy's to distribute Russian vaccine in India. What we know

While Dr Reddy's Labs is preparing for clinical trials of Sputnik V, major manufacturers in the country are sceptical about the drug

Covid-19: Mass production of Sputnik V likely to take several months

Vaccine makers here feel the Sputnik is still a work in progress and needs time to develop

Russian vaccine on its way to India, pact signed with Dr Reddy's for trials

Talks are also on with five major Indian manufacturers here to produce the vaccine for India and the world

Festival spook: Covid-19 cases surge in Mumbai post Ganpati celebrations

Upcoming festival season is likely to push up Covid-19 numbers across the country

Spike in Covid-19 cases bares gaps in Delhi, Mumbai critical care infra

Industry says govt makeshift facilities lie vacant as patients scramble for private hospital beds

Serum Institute of India gets nod to resume Covid-19 vaccine trial

The resumption of trails was allowed after the vaccine maker submitted recommendations of the Data Safety Monitoring Board (DSMB), the UK, and DSMB, India

Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR

Developing own candidate; to develop and make CSIR vaccine candiates

NPPA extends price cap on knee implants by a year to September 2021

A few weeks back, the pricing regulator had extended the price cap by a month after the earlier order validity ended in August

Paracetamol curbs amid Covid-19 pandemic dent sales during monsoon

Sales of paracetamol are typically high during monsoon when cold and flu ailments are common